This review outlines advances in targeting #oncogenic #KRAS, detailing #RASpathway biology, emerging inhibitors, and combination strategies, while also highlighting resistance mechanisms and current #ClinicalTrial progress. #cancer #medsky
#OpenAccess in #STTT: doi.org/10.1038/s413...
1
0
0
0